OrsoBio to Present Preclinical and Clinical Data from Its Mitochondrial Protonophore Portfolio at ADA 2026 Scientific Sessions OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for obesity…
CicadaBio to Present CC-18, a Novel GLP-1/ActRII Fusion Protein for Muscle-Sparing Weight Loss, at ADA 2026 CicadaBio has announced new preclinical findings for CC-18, its investigational dual-pathway fusion protein targeting…
Beyond Anti-Aging: AV Laboratories Elevates Amino Acids as the Core of Science-Driven Skin Longevity At the AVL Molecular Research Center at the University of Colorado Boulder, AV Laboratories is conducting…
Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award John M. Kane, MD, a leading figure in schizophrenia research and co-director of the Institute of…
LivaNova Names Anne Liddy as Chief Legal Officer LivaNova PLC, a global medical technology company specializing in advanced therapeutic solutions, has announced the appointment of Anne Liddy as its new…
Glooko Launches First-Ever Insulin Pump Settings EHR Integration to Streamline Clinical Workflows and Data Access Glooko, Inc., a global digital health company focused on improving diabetes management and supporting clinicians…
Gilead Highlights Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa Gilead Sciences has commended the leadership of the Government of South Africa and the Global Fund for…
Azafaros Announces Publication of Phase 2 RAINBOW Study Results for Nizubaglustat in Molecular Genetics and Metabolism Journal Azafaros, a privately held biotechnology company focused on developing therapies for lysosomal storage…
OliX Pharmaceuticals Raises KRW 110 Billion in Strategic Investment from L’Oréal’s BOLD and Weiss Asset Management OliX Pharmaceuticals, Inc., a leading biotechnology company specializing in RNA interference (RNAi) therapeutics, has…
NEJM Publishes ASCERTAIN-V Trial Results of First All-Oral Decitabine-Cedazuridine Plus Venetoclax Regimen in AML Taiho Oncology, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for hematologic malignancies…
Verastem Oncology’s VS-7375 Receives FDA Fast Track Designation for KRAS G12D-Mutated Non-Small Cell Lung Cancer Verastem Oncology, a biopharmaceutical company focused on developing targeted therapies for cancers driven by the…
VB Spine Partners to Fund Breakthrough Pediatric Scoliosis Genetics Research Led by Dr. Alain Moreau VB Spine LLC, a global, family-owned spine-focused medical company, has announced a strategic partnership to…